DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) said Wednesday that Baxalta Inc. will be the name of the new, publicly traded biopharmaceutical company that is expected to launch in mid-2015.
Upon completion of the separation, Baxalta plans to trade on the New York Stock Exchange under the symbol BXLT. Baxter International will continue trading on the NYSE under the symbol BAX.
The corporate headquarters of both companies will be located in northern Illinois.
In March, Baxter announced its plan to separate into two healthcare companies - one focused on developing biopharmaceuticals and the other on medical products.
Copyright RTT News/dpa-AFX
© 2014 AFX News
